See more : Banco Alfa de Investimento S.A. (BRIV4.SA) Income Statement Analysis – Financial Results
Complete financial analysis of Entero Healthcare Solutions Limited (ENTERO.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Entero Healthcare Solutions Limited, a leading company in the industry within the sector.
- Mega First Corporation Berhad (3069.KL) Income Statement Analysis – Financial Results
- Chicken Soup for the Soul Entertainment, Inc. (CSSE) Income Statement Analysis – Financial Results
- SK Japan Co.,Ltd. (7608.T) Income Statement Analysis – Financial Results
- Pioneer Oil and Gas (POGS) Income Statement Analysis – Financial Results
- PT Nippon Indosari Corpindo Tbk (ROTI.JK) Income Statement Analysis – Financial Results
Entero Healthcare Solutions Limited (ENTERO.NS)
Website: https://www.enterohealthcare.com
About Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, nursing homes, and healthcare clinics in India. It is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. The company was incorporated in 2018 and is based in Mumbai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 39.22B | 33.00B | 25.15B | 17.73B | 13.50B |
| Cost of Revenue | 35.74B | 30.32B | 23.12B | 16.38B | 12.40B |
| Gross Profit | 3.48B | 2.68B | 2.03B | 1.35B | 1.10B |
| Gross Profit Ratio | 8.87% | 8.13% | 8.06% | 7.61% | 8.13% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.52B | 108.13M | 137.42M | 91.41M | 591.95M |
| Selling & Marketing | 44.88M | 272.85M | 248.62M | 132.21M | 3.59M |
| SG&A | 1.56B | 380.98M | 386.04M | 223.62M | 595.54M |
| Other Expenses | 1.09B | 55.14M | 8.86M | 6.05M | 0.00 |
| Operating Expenses | 2.65B | 2.29B | 1.92B | 1.28B | 970.27M |
| Cost & Expenses | 38.35B | 32.60B | 25.04B | 17.66B | 13.37B |
| Interest Income | 133.32M | 40.90M | 34.39M | 29.43M | 87.67M |
| Interest Expense | 656.84M | 489.72M | 260.95M | 163.80M | 0.00 |
| Depreciation & Amortization | 250.17M | 242.37M | 197.54M | 162.76M | 42.71M |
| EBITDA | 1.26B | 694.76M | 260.38M | 254.57M | 169.37M |
| EBITDA Ratio | 3.22% | 2.11% | 1.28% | 1.31% | 1.25% |
| Operating Income | 868.26M | 452.84M | 125.34M | 69.47M | 126.66M |
| Operating Income Ratio | 2.21% | 1.37% | 0.50% | 0.39% | 0.94% |
| Total Other Income/Expenses | -512.71M | -434.58M | -244.95M | -175.12M | -87.99M |
| Income Before Tax | 355.55M | -36.88M | -198.11M | -108.38M | 38.67M |
| Income Before Tax Ratio | 0.91% | -0.11% | -0.79% | -0.61% | 0.29% |
| Income Tax Expense | -42.44M | 74.16M | 96.28M | 45.16M | 25.81M |
| Net Income | 391.09M | -115.57M | -299.20M | -155.37M | 9.44M |
| Net Income Ratio | 1.00% | -0.35% | -1.19% | -0.88% | 0.07% |
| EPS | 8.99 | -2.66 | -6.88 | -3.57 | 0.22 |
| EPS Diluted | 8.99 | -2.66 | -6.88 | -3.57 | 0.22 |
| Weighted Avg Shares Out | 43.49M | 43.50M | 43.50M | 43.50M | 43.50M |
| Weighted Avg Shares Out (Dil) | 43.49M | 43.50M | 43.50M | 43.50M | 43.50M |
Source: https://incomestatements.info
Category: Stock Reports